Using 4-D imaging of the zebrafish model to observe pharmacodynamics of a therapeutic drug on glioblastoma

Público Deposited

Citeable URL: https://ir.library.oregonstate.edu/concern/defaults/ht24wk93x

Descriptions

Attribute Name	Values
Creator	Means, Sophie Gamble, John Wehmas, Leah Greenwood, Julie
Abstract	Glioblastoma Multiform • Type of aggressive brain cancer • Five year survival rate of 4.70% • Not often detected until it’s in the later stages when the symptoms appear • Surgery is not an effective option due to invasion and proliferation of glioblastoma cells outside of the tumor mass before and after surgery Why the Zebrafish Model? • Transparent body • Organism size • Short assay period • Little media required • No adaptive immune system for 28 dpf • Vertebrate anatomy and brain microenvironment
Resource Type	Poster
Fecha Disponible	2016-02-29T14:39:09+00:00
Fecha de Emisión	2015-09-18
Degree Level	Bachelor's
Degree Name	Bachelor of Science (B.S.)
Advisor	Greenwood, Julie
Academic Affiliation	Environmental and Molecular Toxicology Integrative Biology Biochemistry and Biophysics
Non-Academic Affiliation	Oregon State University. Undergraduate Research, Scholarship, and the Arts (URSA)
Declaración de derechos	In Copyright
Funding Statement (additional comments about funding)	SURE Science Scholarship. Award number 1337774 from the National Science Foundation, MRI: Acquisition of Confocal and Two-Photon Excitation Microscope.
Publisher	Oregon State University
Peer Reviewed	No
Language	English [eng]
Replaces	http://hdl.handle.net/1957/58378

Parents:

This work has no parents.

En Collection:

Miniatura	Título	Fecha de subida	Visibilidad	Acciones
	MeansSophieA2016.pdf	2017-07-21	Público	Descargar